retatrutide dosing in trials Retatrutide—A Game Changer Obesity Pharmacotherapy Retatrutide Dosing Guide: 2mg–12mg Protocol

24 This is entirely consistent with the results from many other studies

Eloralintide is not FDA-approved and is not available for prescription

Food Science & Nutrition

However, missing multiple doses in a month reduces weight loss momentum and can lead to gradual regain, making consistent adherence essential for long-term success

The FDA does not certify or approve dietary supplements, so any marketing suggesting FDA endorsement for this product is inherently misleading

Currently, a phase 3 clinical trial program for retatrutide (TRIUMPH) is underway to assess its safety and efficacy in different obese patient populations, including those with obstructive sleep apnea (OSA), T2D, diagnosed cardiovascular disease, osteoarthritis, and others